International Journal of Infection

Published by: Kowsar

Review of the Prevention of the Hepatitis B Virus Infection Transmission From Mother to Child During Pregnancy

Seyed Mohammad Hashemi-Shahri 1 , Batool Sharifi-Mood 1 , * and Manijeh Khalili 2
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Children and Adolescents Health Research Center, Aliebn-E-Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: July 30, 2015, 2 (3); e26626
  • Published Online: July 20, 2015
  • Article Type: Review Article
  • Received: January 2, 2015
  • Accepted: January 14, 2015
  • DOI: 10.17795/iji26626

To Cite: Hashemi-Shahri S M, Sharifi-Mood B, Khalili M. Review of the Prevention of the Hepatitis B Virus Infection Transmission From Mother to Child During Pregnancy, Int J Infect. 2015 ; 2(3):e26626. doi: 10.17795/iji26626.

Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Nelson NP, Jamieson DJ, Murphy TV. Prevention of Perinatal Hepatitis B Virus Transmission. J Pediatric Infect Dis Soc. 2014; 3[DOI][PubMed]
  • 2. Geeta MG, Riyaz A. Prevention of mother to child transmission of hepatitis B infection. Indian Pediatrics. 2013; 50(2): 189-92[DOI]
  • 3. Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of Hepatitis B Surface Antigen and Anti Hepatitis C Antibody in Zahedan City, Iran: A Population-Based Study. Hepat Mon. 2012; 12(9)[DOI]
  • 4. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[DOI]
  • 5. Kaykhah F, Kouhpayeh HR, Metanat M, Khademi R. Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Zahedan, Iran. Hepat Mon. 2004; 4(8): 161-3
  • 6. Sharifi-Mood B, Metanat M, Sanei-Moghaddam E, Khosravi S. Comparison of Prevalence of Hepatitis B Virus Infection in Non Official Barbers with Blood Donors. J Med Sci (Faisalabad). 2006; 6(2): 222-4[DOI]
  • 7. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007; 28(10): 1516-9[PubMed]
  • 8. Sharifi-Mood B, Alavi-Naini R, Salehi M, Hashemi M, Rakhshani F. Spectrum of clinical disease in a series of hospitalized HIV-infected patients from southeast of Iran. Saudi Med J. 2006; 27(9): 1362-6[PubMed]
  • 9. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 10. World Health Organization . Hepatitis B. World Health Organization Fact Sheet 204 (Revised October 2000).
  • 11. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009; 16(2): 94-103[DOI][PubMed]
  • 12. Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011; 30(2): 66-71[DOI][PubMed]
  • 13. Willis BC, Wortley P, Wang SA, Jacques-Carroll L, Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics. 2010; 125(4): 704-11[DOI][PubMed]
  • 14. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54: 1-31[PubMed]
  • 15. Jin H, Zhao Y, Tan Z, Zhang X, Zhao Y, Wang B, et al. Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials. BMC Pediatr. 2014; 14(1): 307[DOI][PubMed]
  • 16. Piñeiro C, Fernandes S, Figueiredo C, Sofia Santos A, Moucho M, Serrão R, et al. Prevention of mother-to-child transmission: experience of a Portuguese centre. Journal Int AIDS Soc. 2014; 17(4(Suppl 3))[DOI]
  • 17. Poovorawan Y, Sanpavat S, Pongpunglert W, Chumdermpadetsuk S, Sentrakul P, VandepapeliÈRe P, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatric Infect Dis J. 1992; 11(10): 816-21[DOI]
  • 18. Wen WH, Chang MH, Chen HL. Reply to: Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention. J Hepat. 2013; 59(2): 401[DOI]
  • 19. Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012; 142(4): 773-781 e2[DOI][PubMed]
  • 20. Ranger-Rogez S, Denis F. Hepatitis B mother--to--child transmission. Expert Rev Anti Infect Ther. 2004; 2(1): 133-45[PubMed]
  • 21. Rumi MA, Begum K, Hassan MS, Hasan SM, Azam MG, Hasan KN, et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg. 1998; 59(2): 318-22[PubMed]
  • 22. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010; 14(7)-34[DOI][PubMed]
  • 23. Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U, et al. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis. 2015; 34(3): 619-23[DOI][PubMed]
  • 24. Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding While Taking Lamivudine or Tenofovir Disoproxil Fumarate: A Review of the Evidence. Clin Infect Dis. 2014; 60(2): 275-8[DOI]
  • 25. Wu Q, Huang H, Sun X, Pan M, He Y, Tan S, et al. Telbivudine Prevents Vertical Transmission of Hepatitis B Virus From Women With High Viral Loads: A Prospective Long-Term Study. Clin Gastroenterol Hepat. 2015; 13(6): 1170-6[DOI]
  • 26. Tsai PS, Chang A, Yamada S, Tsai N, Bartholomew ML. Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women. Digestive Dis Sci. 2014; 59(11): 2797-803[DOI]
  • 27. Nguyen V, Tan PK, Greenup AJ, Glass A, Davison S, Samarasinghe D, et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Alimentary Pharm Ther. 2014; 39(10): 1225-34[DOI]
  • 28. Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatol. 2014; 60(2): 468-76[DOI]
  • 29. Celen MK. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. W J Gastroenterol. 2013; 19(48): 9377[DOI]
  • 30. Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008; 359(23): 2442-55[DOI][PubMed]
  • 31. Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011; 140(1): 132-43[DOI][PubMed]
  • 32. Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010; 116(1): 147-59[DOI][PubMed]
  • 33. Purdy JB, Gafni RI, Reynolds JC, Zeichner S, Hazra R. Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus. J Pediatr. 2008; 152(4): 582-4[DOI][PubMed]
  • 34. Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther. 2011; 16(5): 621-8[DOI][PubMed]
  • 35. Nurutdinova D, Onen NF, Hayes E, Mondy K, Overton ET. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants. Ann Pharmacother. 2008; 42(11): 1581-5[DOI][PubMed]
  • 36. Outcomes of eight Chinese-Americans pregnant patients with chronic hepatitis B (CHB) treated with tenofovir DF (TDF) during pregnancy. Hepatol. : 505A
  • 37. Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr. 2002; 29(3): 207-20[PubMed]
  • 38. Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics. 2006; 118(3)-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments